Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP83437.RA5SRpAUOSsOhff9pwMYhFv2x1b1ACO7OXBIAHnckGQeo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP83437.RA5SRpAUOSsOhff9pwMYhFv2x1b1ACO7OXBIAHnckGQeo130_assertion type Assertion NP83437.RA5SRpAUOSsOhff9pwMYhFv2x1b1ACO7OXBIAHnckGQeo130_head.
- NP83437.RA5SRpAUOSsOhff9pwMYhFv2x1b1ACO7OXBIAHnckGQeo130_assertion description "[We used the allelic discrimination method to identify polymorphisms in GSTT1, SULT1C2, CDA, SXR (drug metabolic pathways), XPD, XPA, XPG, ERCC1, TOP2A (DNA repair), VEGF (angiogenesis), and MDR1 (multidrug resistance) genes in 110 adult patients with intermediate-risk AML, enrolled in the CETLAM-99 prospective trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83437.RA5SRpAUOSsOhff9pwMYhFv2x1b1ACO7OXBIAHnckGQeo130_provenance.
- NP83437.RA5SRpAUOSsOhff9pwMYhFv2x1b1ACO7OXBIAHnckGQeo130_assertion evidence source_evidence_literature NP83437.RA5SRpAUOSsOhff9pwMYhFv2x1b1ACO7OXBIAHnckGQeo130_provenance.
- NP83437.RA5SRpAUOSsOhff9pwMYhFv2x1b1ACO7OXBIAHnckGQeo130_assertion SIO_000772 16507781 NP83437.RA5SRpAUOSsOhff9pwMYhFv2x1b1ACO7OXBIAHnckGQeo130_provenance.
- NP83437.RA5SRpAUOSsOhff9pwMYhFv2x1b1ACO7OXBIAHnckGQeo130_assertion wasDerivedFrom gad-20150221 NP83437.RA5SRpAUOSsOhff9pwMYhFv2x1b1ACO7OXBIAHnckGQeo130_provenance.
- NP83437.RA5SRpAUOSsOhff9pwMYhFv2x1b1ACO7OXBIAHnckGQeo130_assertion wasGeneratedBy ECO_0000203 NP83437.RA5SRpAUOSsOhff9pwMYhFv2x1b1ACO7OXBIAHnckGQeo130_provenance.